hg_133724.1

Basic information about the TSS

---

TSS ID: hg_133724.1 Species: human Chr: chr12		Start: 121352384 End: 121352398 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000541887.5 ENST00000544442.5 ENST00000539871.1 BC001081 BC001950 Distance: 0 GeneID: 51433 HGNC/MGI_ID: HGNC:15713 UniProt_ID: F5GY68 F5H0F9 F5H3S5

Gene_name: anaphase promoting complex subunit 5 Gene_symbol: ANAPC5 Gene_synonyms: APC5 Gene_source: HGNC:15713

TATA-Box annotation

---

Distance to TSS:	20
Nearest PromoterID:	NM_001330489
Entrez ID:	51433
Nearest Unigene:	Hs.7101
Nearest Refseq:	NM_016237
Nearest Ensembl:	ENSG00000089053
Gene Name:	anaphase promoting complex subunit 5
Gene Alias:	APC5
Gene Description:	anaphase promoting complex subunit 5
Gene Type:	protein-coding
CpG%:	0.085
GC%:	0.597015
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ANAPC5 p2@ANAPC5 p3@ANAPC5
Sample		p1@ANAPC5	p2@ANAPC5	p3@ANAPC5
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	69.93	6.43	3.90
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	65.75	12.34	3.64
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	65.78	10.42	3.09
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	56.55	7.69	2.49
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	65.69	6.52	3.37
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	68.22	7.95	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	89.99	13.29	5.23
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	73.88	10.66	2.42
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	78.22	12.18	4.49
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	88.10	5.22	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	63.87	9.30	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	71.55	8.94	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	25.31	4.35	5.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	23.30	3.91	4.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	21.96	3.51	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	21.88	2.26	3.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.66	1.97	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	21.51	3.80	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	20.79	1.60	3.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	20.31	1.65	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	24.06	2.54	4.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	27.62	2.93	3.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	20.16	3.23	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	21.35	0.97	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	21.93	2.58	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	19.94	2.85	3.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	25.28	4.40	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	25.23	0.94	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	21.48	2.91	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	27.51	2.71	3.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	22.82	2.93	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	21.69	3.32	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	30.60	3.38	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	33.48	3.79	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	21.13	2.80	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	22.61	3.07	2.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	19.62	2.86	4.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	20.55	3.02	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	22.69	2.16	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	21.37	3.84	2.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	15.53	2.82	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	28.84	4.68	2.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	24.46	5.27	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	24.65	3.15	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	20.48	3.41	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	22.33	2.33	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	20.39	3.60	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	19.37	5.96	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	20.35	3.35	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.85	3.64	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	30.54	2.46	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	25.80	5.78	4.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	97.95	13.99	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	22.71	3.90	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	25.52	2.32	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	46.98	9.23	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	33.52	5.97	4.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	24.96	4.54	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	25.05	4.50	2.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	30.49	5.03	3.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	26.79	3.53	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	26.92	3.36	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	29.46	3.18	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	31.94	6.46	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	25.67	2.60	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	25.56	4.61	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	32.33	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	15.79	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	31.69	5.36	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	34.22	3.47	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	27.68	4.69	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	31.79	4.97	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	31.55	5.26	4.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.05	4.59	2.14
Adipocyte - breast, donor1	11376-118A8	59.08	8.39	2.22
Adipocyte - breast, donor2	11327-117E4	30.00	5.29	1.60
Adipocyte - omental, donor1	11473-119C6	45.67	7.63	1.91
Adipocyte - omental, donor2	11474-119C7	24.67	6.73	3.74
Adipocyte - omental, donor3	11475-119C8	25.12	5.69	4.02
Adipocyte - perirenal, donor1	11476-119C9	44.66	6.38	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	19.79	3.30	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	55.10	11.29	8.58
Adipocyte - subcutaneous, donor3	11408-118E4	30.41	4.52	4.52
Adipocyte differentiation, day04, donor1	13019-139D4	30.90	3.52	3.91
Adipocyte differentiation, day04, donor2	13022-139D7	29.86	3.86	2.06
Adipocyte differentiation, day04, donor3	13025-139E1	30.66	3.35	2.51
Adipocyte differentiation, day04, donor4	13028-139E4	24.69	2.94	3.53
Adipocyte differentiation, day08, donor1	13020-139D5	33.54	3.30	4.91
Adipocyte differentiation, day08, donor2	13023-139D8	33.24	2.90	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	20.79	2.67	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	25.60	4.45	2.23
Adipocyte differentiation, day12, donor1	13021-139D6	28.70	6.65	2.08
Adipocyte differentiation, day12, donor2	13024-139D9	28.88	4.77	3.27
Adipocyte differentiation, day12, donor3	13027-139E3	29.45	2.62	3.27
Adipocyte differentiation, day12, donor4	13030-139E6	17.66	1.52	1.22
Alveolar Epithelial Cells, donor1	11510-119G7	46.85	6.41	5.52
Alveolar Epithelial Cells, donor2	11590-120G6	12.19	3.23	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	20.37	3.59	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	53.43	8.10	3.06
Amniotic Epithelial Cells, donor2	11613-122A2	30.12	5.02	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	42.12	5.75	1.85
Anulus Pulposus Cell, donor1	11248-116E6	62.82	6.18	5.49
Anulus Pulposus Cell, donor2	11463-119B5	32.33	4.65	2.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	18.42	2.25	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	27.35	3.91	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	32.10	4.28	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	25.41	3.29	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	32.88	3.79	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	20.46	5.28	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	28.91	5.20	2.92
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	28.16	4.85	4.85
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	27.32	2.97	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	24.86	4.90	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.77	7.26	3.63
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	36.36	2.51	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	43.00	6.42	3.79
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	27.30	4.09	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	39.05	5.73	2.26
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	27.86	2.14	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	21.92	6.23	3.02
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	36.89	4.54	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	22.44	0.98	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	21.06	3.15	3.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	34.82	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	49.56	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	25.56	3.26	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	35.44	4.85	4.85
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	26.56	4.93	2.66
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	33.92	7.27	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	18.24	4.56	3.99
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	32.92	3.63	2.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	26.33	5.68	1.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	22.99	2.35	2.82
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	25.08	4.82	2.57
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.82	4.28	4.99
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.23	3.51	3.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	30.41	3.31	5.12
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	33.26	7.13	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	27.97	4.07	4.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	26.74	2.80	4.08
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	31.77	1.91	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	27.62	2.16	2.59
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.46	4.02	2.33
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	23.78	2.61	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	29.29	5.67	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	29.50	5.09	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	34.75	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	38.03	4.23	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	27.44	5.79	3.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.68	1.20	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	24.79	7.29	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	28.05	4.60	2.30
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	7.65	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	41.69	4.83	4.07
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	29.93	4.13	4.13
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	27.54	3.37	4.59
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	24.86	4.78	2.39
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	23.28	4.21	2.88
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	32.04	3.05	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	30.46	1.11	4.43
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	27.80	3.18	3.71
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	22.53	2.54	1.09
Astrocyte - cerebellum, donor1	11500-119F6	72.46	10.93	7.49
Astrocyte - cerebellum, donor2	11580-120F5	42.62	6.85	4.79
Astrocyte - cerebellum, donor3	11661-122F5	23.49	3.15	2.94
Astrocyte - cerebral cortex, donor1	11235-116D2	53.33	5.23	6.27
Astrocyte - cerebral cortex, donor2	11316-117D2	44.49	4.37	8.90
Astrocyte - cerebral cortex, donor3	11392-118C6	46.84	8.05	6.41
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	63.77	9.63	8.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	73.29	11.28	9.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	65.55	7.85	7.85
Basophils, donor1	12241-129G9	46.81	8.37	2.88
Basophils, donor2	12242-129H1	72.88	10.46	3.97
Basophils, donor3	12243-129H2	42.78	7.06	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	36.01	5.39	2.59
Bronchial Epithelial Cell, donor2	11591-120G7	8.23	0.91	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	33.27	3.14	3.77
Bronchial Epithelial Cell, donor5	11457-119A8	28.07	4.16	3.95
Bronchial Epithelial Cell, donor6	11461-119B3	28.79	4.15	3.22
Bronchial Epithelial Cell, donor7	11769-123I5	27.71	4.14	3.24
Burkitt's lymphoma cell line:DAUDI	10422-106C8	105.84	14.22	4.84
Burkitt's lymphoma cell line:RAJI	10476-106I8	163.27	20.26	8.62
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	115.12	23.66	4.80
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	41.37	0.00
CD14+ Monocytes, donor1	11224-116B9	50.72	4.51	1.13
CD14+ Monocytes, donor2	11305-117B9	31.00	4.27	1.48
CD14+ Monocytes, donor3	11381-118B4	42.15	7.90	1.76
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	48.68	5.09	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	53.45	4.55	2.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	44.71	3.62	2.63
CD14+ monocytes - mock treated, donor1	11863-125A9	16.04	2.17	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	11.16	3.92	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	17.29	3.55	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	11.89	2.34	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6.90	1.38	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	11.65	2.48	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	9.20	1.37	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	11.40	1.25	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	18.06	4.13	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	13.35	1.87	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.73	9.50	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	15.53	4.44	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	10.41	1.49	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	11.77	1.60	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	20.40	2.91	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	12.58	1.83	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.67	3.62	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	11.35	3.06	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	11.57	1.88	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	13.78	2.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	16.83	2.95	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	9.19	1.10	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.75	2.11	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	9.21	1.32	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	10.29	1.74	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	11.15	2.97	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	18.32	3.45	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	7.78	1.23	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	12.98	1.85	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	13.92	3.94	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	62.56	9.81	3.49
CD14+CD16+ Monocytes, donor2	11801-124D1	66.06	7.39	3.46
CD14+CD16+ Monocytes, donor3	11912-125G4	64.77	6.72	3.03
CD14+CD16- Monocytes, donor1	11788-124B6	78.33	6.38	2.65
CD14+CD16- Monocytes, donor2	11799-124C8	68.81	7.68	2.45
CD14+CD16- Monocytes, donor3	11910-125G2	61.54	8.47	2.01
CD14-CD16+ Monocytes, donor1	11790-124B8	58.43	6.63	3.57
CD14-CD16+ Monocytes, donor2	11800-124C9	63.45	7.47	3.29
CD14-CD16+ Monocytes, donor3	11911-125G3	61.27	5.47	3.37
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	107.71	2.03	8.13
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	110.51	13.56	7.46
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	107.70	7.25	9.32
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	117.80	10.13	8.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	114.72	9.65	11.26
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	117.22	11.93	6.32
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	103.53	12.55	9.41
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	129.19	18.46	11.86
CD19+ B Cells, donor1	11544-120B5	90.41	9.04	1.64
CD19+ B Cells, donor2	11624-122B4	58.03	7.98	0.73
CD19+ B Cells, donor3	11705-123B4	49.47	8.58	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	108.69	14.14	12.12
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	89.49	11.59	11.59
CD34+ Progenitors, donor1	11545-120B6	77.31	5.02	0.00
CD34+ Progenitors, donor2	11625-122B5	57.30	12.92	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	119.87	18.41	7.89
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	134.61	28.64	4.28
CD4+ T Cells, donor1	11225-116C1	114.97	17.14	4.28
CD4+ T Cells, donor2	11306-117C1	77.77	9.80	4.90
CD4+ T Cells, donor3	11382-118B5	75.33	9.45	3.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	124.56	12.25	8.17
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	117.69	11.45	6.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	109.81	9.20	5.75
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	113.78	11.85	7.59
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	129.93	13.34	6.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	112.07	3.30	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	95.52	11.56	4.48
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	75.58	11.69	5.08
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	65.77	6.77	3.87
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	119.25	14.35	7.62
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	111.80	17.12	6.99
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	134.63	18.48	4.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	127.76	14.76	4.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	67.53	9.97	5.82
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	68.50	5.35	2.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	128.35	10.61	9.25
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	149.53	13.93	4.82
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	98.63	5.38	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	131.47	17.62	5.01
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	88.16	12.13	5.63
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	84.69	11.35	5.25
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	107.69	9.61	6.57
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	115.68	15.60	4.77
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	121.59	14.82	8.72
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	144.01	16.33	7.42
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	113.55	12.00	13.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	164.71	13.96	6.98
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	130.16	15.51	10.25
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	153.12	15.95	11.53
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	152.46	12.32	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	135.73	14.68	9.31
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	175.89	9.69	8.31
CD8+ T Cells, donor1	11226-116C2	96.91	14.08	3.60
CD8+ T Cells, donor2	11307-117C2	67.20	10.51	1.50
CD8+ T Cells, donor3	11383-118B6	82.56	13.38	5.30
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	31.20	8.95	2.75
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	34.51	5.51	1.68
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	32.56	7.11	3.28
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	40.83	9.91	4.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	24.48	7.68	2.40
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	32.52	8.64	2.27
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	39.33	8.26	2.39
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	29.74	7.37	2.11
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	37.52	7.50	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	39.55	7.85	3.02
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	40.09	6.97	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	31.44	11.46	2.66
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.07	4.82	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	23.68	5.01	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.16	5.97	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	31.69	6.48	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	32.22	8.06	3.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	29.46	6.36	3.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	35.18	11.73	2.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	38.14	10.15	3.08
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	32.06	11.22	2.24
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.16	8.80	1.91
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	26.80	8.67	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.01	5.29	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	36.94	3.21	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	30.08	4.90	6.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	20.04	7.01	4.01
Cardiac Myocyte, donor1	11525-119I4	5.48	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	37.06	1.98	3.95
Cardiac Myocyte, donor3	11686-122I3	38.62	4.31	6.52
Chondrocyte - de diff, donor1	11261-116G1	42.29	7.28	7.97
Chondrocyte - de diff, donor2	11338-117F6	38.03	9.24	1.78
Chondrocyte - de diff, donor3	11410-118E6	31.63	5.01	2.62
Chondrocyte - re diff, donor2	11339-117F7	63.56	13.43	2.69
Chondrocyte - re diff, donor3	11411-118E7	47.72	10.51	5.66
Ciliary Epithelial Cells, donor1	11242-116D9	68.17	5.05	7.92
Ciliary Epithelial Cells, donor2	11323-117D9	48.95	6.41	4.28
Ciliary Epithelial Cells, donor3	11399-118D4	46.64	5.40	5.93
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	51.90	7.06	6.14
Corneal Epithelial Cells, donor1	11526-119I5	27.23	2.42	3.29
Corneal Epithelial Cells, donor2	11606-120I4	45.50	2.28	2.28
Corneal Epithelial Cells, donor3	11687-122I4	31.44	5.37	3.83
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	30.54	4.29	1.82
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	31.86	4.10	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	10.35	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	27.75	6.05	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	136.31	19.47	3.42
Dendritic Cells - plasmacytoid, donor2	11309-117C4	128.62	18.28	7.18
Dendritic Cells - plasmacytoid, donor3	11385-118B8	117.11	15.49	3.39
Endothelial Cells - Aortic, donor0	11207-116A1	34.02	3.00	2.84
Endothelial Cells - Aortic, donor1	11263-116G3	31.69	5.28	4.11
Endothelial Cells - Aortic, donor2	11340-117F8	39.87	7.07	2.55
Endothelial Cells - Aortic, donor3	11412-118E8	34.21	4.33	2.36
Endothelial Cells - Artery, donor1	11264-116G4	30.83	5.53	2.62
Endothelial Cells - Artery, donor2	11341-117F9	31.76	4.47	1.65
Endothelial Cells - Artery, donor3	11413-118E9	34.71	7.71	3.86
Endothelial Cells - Lymphatic, donor1	11236-116D3	55.86	6.87	2.88
Endothelial Cells - Lymphatic, donor2	11317-117D3	56.29	7.61	2.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	54.69	8.46	3.66
Endothelial Cells - Microvascular, donor1	11265-116G5	47.84	5.65	2.38
Endothelial Cells - Microvascular, donor2	11342-117G1	35.41	3.64	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	26.37	3.83	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	57.22	10.80	2.40
Endothelial Cells - Thoracic, donor2	11343-117G2	30.92	4.72	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	94.92	13.67	6.96
Endothelial Cells - Umbilical vein, donor2	11324-117E1	40.19	5.87	3.91
Endothelial Cells - Umbilical vein, donor3	11400-118D5	46.65	7.33	3.18
Endothelial Cells - Vein, donor1	11267-116G7	29.58	3.41	1.14
Endothelial Cells - Vein, donor2	11344-117G3	41.21	8.38	2.10
Endothelial Cells - Vein, donor3	11416-118F3	38.62	6.91	1.57
Eosinophils, donor1	12244-129H3	15.25	30.49	0.00
Eosinophils, donor2	12245-129H4	37.96	6.60	1.65
Eosinophils, donor3	12246-129H5	49.94	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	27.85	2.69	2.44
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	4.16	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	40.23	6.16	2.46
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	20.26	4.82	1.97
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	33.26	6.39	2.93
Fibroblast - Aortic Adventitial, donor1	11245-116E3	56.27	7.16	4.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	48.99	5.73	5.32
Fibroblast - Aortic Adventitial, donor2	11326-117E3	27.74	4.22	4.43
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	38.47	2.37	5.01
Fibroblast - Aortic Adventitial, donor3	11401-118D6	35.88	7.31	4.98
Fibroblast - Cardiac, donor1	11268-116G8	30.85	5.44	3.18
Fibroblast - Cardiac, donor2	11345-117G4	41.69	4.55	5.31
Fibroblast - Cardiac, donor3	11417-118F4	19.56	4.57	2.52
Fibroblast - Cardiac, donor4	11452-119A3	57.59	4.24	3.33
Fibroblast - Cardiac, donor5	11456-119A7	46.70	6.98	4.31
Fibroblast - Cardiac, donor6	11460-119B2	44.42	5.46	4.55
Fibroblast - Choroid Plexus, donor1	11492-119E7	63.91	8.17	5.76
Fibroblast - Choroid Plexus, donor2	11572-120E6	36.67	2.16	5.61
Fibroblast - Choroid Plexus, donor3	11653-122E6	52.73	4.39	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	51.89	7.38	11.30
Fibroblast - Conjunctival, donor3	11692-122I9	48.85	4.07	2.88
Fibroblast - Dermal, donor1	11269-116G9	38.74	7.98	4.46
Fibroblast - Dermal, donor2	11346-117G5	54.24	6.13	4.25
Fibroblast - Dermal, donor3	11418-118F5	41.58	5.20	4.71
Fibroblast - Dermal, donor4	11450-119A1	48.04	7.35	7.69
Fibroblast - Dermal, donor5	11454-119A5	50.07	8.37	7.50
Fibroblast - Dermal, donor6	11458-119A9	59.77	7.96	9.75
Fibroblast - Gingival, donor1	11237-116D4	64.76	9.16	3.96
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	46.37	8.12	2.62
Fibroblast - Gingival, donor2	11318-117D4	51.79	7.12	8.17
Fibroblast - Gingival, donor3	11394-118C8	34.52	4.64	4.06
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	35.32	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	21.32	2.11	3.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	45.68	4.83	5.30
Fibroblast - Gingival, donor6 (control)	11922-125H5	37.73	5.00	3.25
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	25.76	3.53	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	49.72	5.85	4.24
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	55.50	6.00	4.50
Fibroblast - Gingival, donor8 (control)	11926-125H9	44.86	6.80	5.16
Fibroblast - Gingival, donor9 (control)	11927-125I1	37.12	3.82	4.11
Fibroblast - Lung, donor1	11270-116H1	29.91	4.08	4.08
Fibroblast - Lung, donor2	11347-117G6	41.78	5.97	1.49
Fibroblast - Lung, donor3	11419-118F6	38.83	6.75	4.43
Fibroblast - Lymphatic, donor1	11506-119G3	70.81	9.16	6.66
Fibroblast - Lymphatic, donor2	11586-120G2	27.97	4.20	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	17.63	2.24	1.12
Fibroblast - Mammary, donor1	11540-120B1	81.60	14.21	5.68
Fibroblast - Mammary, donor2	11620-122A9	43.94	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	11.91	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	76.04	9.31	8.53
Fibroblast - Periodontal Ligament, donor2	11319-117D5	52.79	7.43	6.83
Fibroblast - Periodontal Ligament, donor3	11395-118C9	64.56	6.43	7.04
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	38.16	4.58	5.72
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	28.62	4.86	3.51
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	21.80	3.94	2.55
Fibroblast - Pulmonary Artery, donor1	11250-116E8	58.69	8.40	6.63
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	62.18	7.31	5.08
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	48.78	9.35	4.01
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	34.00	5.54	4.74
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	49.41	5.56	5.56
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	42.10	3.91	3.55
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	53.21	5.32	3.15
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	50.84	7.22	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	49.23	6.05	4.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	43.78	6.07	3.80
Fibroblast - skin normal, donor1	11553-120C5	54.31	8.86	4.10
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	58.15	5.61	5.01
Fibroblast - skin normal, donor2	11561-120D4	47.62	7.23	4.32
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	58.33	4.23	4.23
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	47.64	5.80	4.39
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	53.17	4.79	4.44
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	63.06	6.90	2.96
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	56.78	9.27	6.07
Fibroblast - skin walker warburg, donor1	11554-120C6	56.34	7.08	6.41
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	41.24	10.51	4.08
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	221.60	110.80	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	64.49	11.33	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	44.21	6.07	1.56
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	36.43	3.38	1.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	30.41	6.90	3.32
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	68.13	5.36	6.89
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	62.53	12.76	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	53.06	6.28	5.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	47.15	5.24	6.07
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	29.00	3.65	4.11
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	42.80	5.15	5.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	40.44	4.49	5.29
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	43.38	4.24	5.22
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	57.93	5.75	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	54.69	9.75	6.92
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	43.96	8.25	4.80
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	42.98	11.55	2.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	30.85	3.59	3.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	36.96	4.29	4.57
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	39.03	4.68	3.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	37.19	3.65	3.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	34.75	3.99	4.86
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	37.38	6.12	3.28
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	33.68	5.32	3.55
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	37.51	6.99	4.45
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	39.77	4.02	2.23
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	40.13	4.23	3.43
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	43.26	4.92	4.92
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	60.21	5.41	3.90
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	50.05	6.04	5.72
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	46.28	4.61	3.93
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	38.73	4.98	4.65
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	64.56	7.82	5.07
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	55.95	7.76	3.47
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	35.69	3.92	3.71
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	38.51	6.34	5.76
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	44.36	7.00	5.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	35.71	2.65	4.19
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	47.84	5.90	6.64
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	39.87	7.46	4.21
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	38.81	3.85	4.17
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	42.45	6.06	3.51
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	45.08	5.85	4.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	39.84	3.65	3.65
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	42.76	6.06	3.14
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	44.13	3.95	5.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	40.68	4.21	4.21
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	41.02	7.41	2.69
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	51.07	9.36	3.48
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	42.99	7.04	3.06
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	47.28	8.55	3.63
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	59.91	7.05	2.71
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	46.64	4.61	4.06
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	41.67	7.24	4.17
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	42.65	8.93	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	39.44	8.05	2.37
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	39.75	5.45	5.25
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	57.69	10.17	4.83
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	74.85	11.15	5.77
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	41.29	8.17	3.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	61.78	10.43	4.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	84.80	8.76	7.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	69.51	6.78	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	51.65	9.69	6.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	42.07	7.42	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	58.79	8.51	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	64.18	14.44	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	48.69	10.43	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	52.73	7.81	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	58.89	7.00	6.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	6.66	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	49.78	6.43	6.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	50.01	6.54	6.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	52.01	6.71	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	62.02	7.00	4.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	47.89	7.47	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	6.26	10.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	64.72	8.02	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	45.58	5.33	5.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	52.52	3.39	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	59.23	8.28	6.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	49.48	6.90	4.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	51.13	5.77	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	50.20	6.19	3.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	42.81	6.02	5.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	56.63	7.32	10.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	58.88	13.01	7.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	62.12	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	59.92	6.61	7.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	57.94	3.62	7.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	55.45	6.10	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	53.44	5.98	7.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	53.28	7.40	9.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	68.47	4.72	11.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	56.59	4.67	5.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	68.03	7.02	7.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	49.17	3.39	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	48.35	6.57	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	43.67	4.37	7.28
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	38.80	4.57	4.57
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	31.60	2.08	3.33
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	58.47	3.37	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.96	2.54	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	27.99	4.18	4.18
Hep-2 cells mock treated, biol_rep1	11898-125E8	62.78	8.94	5.11
Hep-2 cells mock treated, biol_rep2	11899-125E9	74.95	13.00	5.74
Hep-2 cells mock treated, biol_rep3	11900-125F1	66.89	11.83	4.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	71.16	10.60	4.26
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	64.04	9.89	5.80
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	68.46	12.27	3.66
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	62.27	9.09	4.73
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	58.16	11.84	3.60
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	55.42	11.21	2.56
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	36.38	5.04	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	20.34	4.33	2.60
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	10.58	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	67.37	9.52	6.70
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	34.87	3.63	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	45.11	7.52	5.59
Hepatocyte, donor1	11523-119I2	50.85	9.68	2.42
Hepatocyte, donor2	11603-120I1	58.18	2.15	4.31
Hepatocyte, donor3	11684-122I1	44.79	3.68	4.29
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	70.49	5.87	6.53
Intestinal epithelial cells (polarized), donor1	11246-116E4	69.74	14.33	2.27
Iris Pigment Epithelial Cells, donor1	11530-119I9	41.44	6.59	3.16
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	31.84	19.10	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	37.38	8.31	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	42.55	5.01	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	11.87	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	64.07	10.25	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	54.85	18.28	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	55.23	8.12	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	61.69	18.34	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	25.41	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	82.06	21.18	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	62.08	14.41	4.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	59.21	14.49	5.04
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	52.59	21.65	6.19
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	40.05	7.75	3.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	66.01	17.71	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	11.95	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	51.34	11.41	6.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	77.66	11.75	2.94
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	52.24	12.06	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	47.09	10.16	7.39
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	47.20	8.50	6.14
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	44.44	6.35	5.44
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	46.27	11.84	4.30
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	63.52	15.25	6.35
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	42.09	9.57	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	63.79	12.76	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	39.99	9.28	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	59.73	3.32	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	45.68	6.79	3.40
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	49.17	12.29	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	62.86	3.14	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	45.90	9.04	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	50.90	11.07	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	61.60	19.45	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	47.96	8.72	6.98
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	42.75	4.50	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	3.48	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	39.47	7.47	7.47
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	48.49	11.08	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	59.84	5.70	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	44.18	5.52	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	15.13	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	34.89	9.52	4.23
Keratinocyte - epidermal, donor1	11272-116H3	43.98	3.51	2.28
Keratinocyte - epidermal, donor2	11349-117G8	31.62	5.27	0.00
Keratinocyte - epidermal, donor3	11421-118F8	33.13	4.92	4.64
Keratinocyte - oral, donor1	11251-116E9	57.67	7.95	5.11
Keratocytes, donor1	11527-119I6	31.98	2.06	11.00
Keratocytes, donor2	11607-120I5	44.53	7.03	5.86
Keratocytes, donor3	11688-122I5	20.15	1.19	6.32
Krukenberg tumor cell line:HSKTC	10687-109F3	41.76	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	34.52	9.71	8.63
Lens Epithelial Cells, donor2	11609-120I7	37.02	3.58	4.61
Lens Epithelial Cells, donor3	11690-122I7	38.95	5.45	4.74
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	42.45	6.76	1.90
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	32.65	3.91	1.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	40.45	4.56	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	22.58	7.53	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	29.00	2.52	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	29.86	4.64	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	32.83	2.87	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	31.86	4.55	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	28.29	4.36	2.11
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	19.78	3.96	3.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	30.44	3.49	2.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	29.25	4.63	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	33.45	3.83	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	30.53	4.05	1.91
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	31.73	2.61	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	28.33	3.70	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	25.56	1.56	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	30.01	4.03	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	28.30	4.61	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	29.58	3.51	2.05
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	30.87	3.73	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	29.10	7.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	26.39	3.50	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	36.94	4.39	1.06
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	25.40	3.63	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	32.66	5.65	1.68
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	34.44	4.66	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	25.45	0.69	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	29.54	2.82	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.63	4.88	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.02	6.78	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	29.44	3.64	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	27.88	5.08	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	34.43	1.85	2.59
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	25.45	3.21	1.98
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	30.11	3.99	1.10
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	28.63	3.54	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	31.04	3.65	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	34.43	3.36	1.54
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.04	4.27	2.49
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	32.00	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	22.41	2.18	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	25.43	4.66	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	27.77	1.96	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	20.48	3.53	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	31.19	4.58	1.73
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	20.49	3.33	1.79
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	20.59	3.88	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	63.45	9.06	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	56.77	16.88	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	45.28	14.84	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	68.55	13.54	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	42.20	14.07	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	38.29	15.88	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	54.62	6.70	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	40.44	8.33	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	61.30	13.35	3.17
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	54.09	9.60	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	45.47	8.10	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	70.45	13.96	2.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	53.41	13.87	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	55.05	10.94	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	39.31	8.00	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	66.22	20.88	4.58
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	46.69	10.41	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	55.93	13.42	2.46
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	65.04	15.34	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	40.77	14.68	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	59.77	10.41	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	54.93	13.73	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	36.06	19.58	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	54.58	11.03	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	63.37	10.46	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	45.92	14.38	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	49.13	11.67	2.47
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	61.22	10.33	2.58
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	40.29	11.51	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	59.48	15.35	4.22
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	62.27	11.32	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	40.20	8.20	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	51.51	7.68	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	51.71	10.05	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	46.31	8.96	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	54.25	10.78	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	49.97	12.06	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	46.24	11.13	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	49.31	10.99	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	48.87	10.26	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	36.97	14.93	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	58.43	12.03	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	52.60	12.35	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	45.79	10.77	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	48.52	16.67	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	68.61	9.30	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	45.48	16.92	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	46.42	9.60	3.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	58.88	8.72	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	49.06	13.80	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	49.82	9.37	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	52.69	8.47	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	48.77	13.58	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	59.48	9.46	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	44.75	12.05	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	44.53	16.03	3.56
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	56.31	12.51	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	48.16	11.88	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	50.85	7.26	4.67
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	63.01	12.25	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	81.63	8.95	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	51.23	7.51	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	59.40	11.19	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	56.21	9.62	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	66.33	9.13	6.25
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	53.67	6.76	3.58
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	70.48	10.33	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	44.96	14.53	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	57.38	15.58	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	51.13	12.39	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	42.93	12.70	3.02
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	51.02	14.58	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	65.04	14.39	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	45.40	16.09	3.45
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	77.14	14.91	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	67.91	9.20	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	43.13	14.75	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	57.83	11.23	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	56.38	7.05	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	43.01	8.35	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	61.33	10.69	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	59.55	10.04	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	45.44	14.44	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	54.55	14.95	4.04
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	54.15	10.10	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	45.34	14.23	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	61.55	13.68	4.56
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	48.31	7.67	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	42.13	10.40	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	44.99	14.70	4.01
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	76.17	17.94	3.38
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	57.03	9.95	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	51.97	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	31.91	5.24	2.51
Macrophage - monocyte derived, donor2	11313-117C8	30.28	5.69	1.65
Macrophage - monocyte derived, donor3	11389-118C3	28.05	3.01	1.57
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	59.47	7.97	5.31
Mallassez-derived cells, donor2	11929-125I3	47.54	7.76	1.27
Mallassez-derived cells, donor3	11930-125I4	54.62	6.39	1.67
Mammary Epithelial Cell, donor1	11273-116H4	55.30	6.08	3.99
Mammary Epithelial Cell, donor2	11350-117G9	43.72	8.40	3.47
Mammary Epithelial Cell, donor3	11422-118F9	23.45	6.98	1.75
Mast cell - stimulated, donor1	11487-119E2	34.57	3.39	1.36
Mast cell, donor1	11563-120D6	40.01	7.25	2.49
Mast cell, donor2	11565-120D8	53.19	8.32	3.57
Mast cell, donor3	11566-120D9	62.36	7.88	4.05
Mast cell, donor4	11567-120E1	48.75	6.38	3.72
Mast cell, expanded and stimulated, donor5	11940-126A5	71.97	9.76	3.44
Mast cell, expanded and stimulated, donor8	11942-126A7	82.30	12.26	4.09
Mast cell, expanded, donor5	11939-126A4	63.33	9.75	3.21
Mast cell, expanded, donor8	11941-126A6	76.15	12.22	2.18
Melanocyte - dark, donor1	11502-119F8	56.61	8.06	2.09
Melanocyte - dark, donor2	11582-120F7	29.07	3.81	3.81
Melanocyte - dark, donor3	11663-122F7	79.54	13.18	3.91
Melanocyte - light, donor1	11274-116H5	39.02	5.17	1.41
Melanocyte - light, donor2	11351-117H1	51.18	12.28	2.73
Melanocyte - light, donor3	11423-118G1	39.03	5.20	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	60.60	9.89	5.31
Melanocyte, donor2 (MC+2)	12739-135I3	83.64	9.14	4.03
Melanocyte, donor3 (MC+3)	12837-137B2	57.32	9.64	2.95
Meningeal Cells, donor1	11493-119E8	91.18	8.06	9.55
Meningeal Cells, donor2	11573-120E7	42.25	8.36	5.72
Meningeal Cells, donor3	11654-122E7	66.34	7.99	5.95
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	65.59	9.41	9.12
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	47.00	6.94	3.62
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	18.31	5.23	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	43.06	8.61	4.31
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	31.98	4.45	2.75
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	23.62	2.51	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	72.96	10.33	9.01
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	64.29	9.50	7.31
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	43.17	7.57	5.73
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	43.77	5.68	4.71
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	22.68	2.97	2.97
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	43.16	3.68	4.47
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	25.52	3.86	2.08
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	57.00	8.33	7.04
Mesenchymal stem cells - adipose, donor0	11217-116B2	88.97	11.70	7.80
Mesenchymal stem cells - hepatic, donor0	11218-116B3	45.66	3.75	3.75
Mesenchymal stem cells - umbilical, donor0	11214-116A8	51.52	4.35	7.98
Mesothelial Cells, donor1	11247-116E5	46.94	4.24	4.77
Mesothelial Cells, donor2	12156-128G5	32.03	5.00	2.50
Mesothelial Cells, donor3	11402-118D7	24.57	2.96	2.46
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5.40	0.00	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	22.16	6.65	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	26.50	6.77	1.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	24.80	4.34	2.17
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.03	2.28	1.66
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	24.28	2.75	1.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	28.39	4.65	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	24.39	2.24	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	28.11	4.75	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	18.58	1.77	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	33.05	4.56	2.66
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	18.68	2.55	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.97	0.92	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.82	4.77	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	20.07	2.51	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	19.25	4.52	2.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.08	1.11	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	14.04	2.99	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	21.45	3.58	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	11.62	2.24	1.02
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.88	3.22	1.50
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	20.45	3.11	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.61	2.41	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.65	1.01	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	13.59	1.90	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	23.82	2.94	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	13.94	1.92	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.81	2.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	1.37	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.01	0.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	16.64	1.75	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.14	2.98	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	8.35	1.39	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	13.33	2.05	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.56	1.75	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.52	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.96	1.96	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.05	2.91	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	10.49	1.75	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	13.88	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	22.96	2.50	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	15.70	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	17.07	2.85	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.33	1.52	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	2.07	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	19.30	3.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.99	1.27	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	10.94	2.14	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	21.85	3.89	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.32	1.55	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	17.84	2.23	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.32	4.20	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.38	2.28	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	16.76	4.55	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	19.91	2.95	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	13.53	2.06	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	17.59	5.19	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	19.37	0.41	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.76	2.38	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	3.56	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	23.33	1.31	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	14.73	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	25.70	4.35	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	22.35	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	20.65	3.00	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	12.52	1.07	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	26.92	4.52	1.58
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	15.47	2.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	19.42	3.30	2.56
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	24.58	2.14	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	20.20	4.04	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	12.23	2.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	0.00	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	13.59	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	22.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	45.89	8.19	5.39
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	31.88	4.18	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	17.35	2.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.86	1.67	2.50
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	26.24	5.13	5.51
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	35.11	6.38	6.38
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	1.36	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	69.83	3.68	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	16.74	2.51	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	22.31	2.09	2.79
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	16.21	1.62	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	19.34	2.10	2.73
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	22.27	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	23.33	1.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	19.22	3.25	2.98
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	22.67	2.49	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.33	2.29	1.63
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	21.69	2.37	3.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.97	3.18	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.00	1.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	22.97	2.30	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	19.03	1.79	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	16.40	1.59	1.23
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	13.36	2.11	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	19.77	1.38	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	20.89	3.21	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	19.66	1.72	4.48
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	42.98	5.06	17.70
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.26	2.45	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.09	2.12	2.96
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.89	2.85	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	23.61	5.58	3.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	99.31	9.03	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	19.99	2.33	2.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	19.39	1.80	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	21.43	3.17	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	25.07	3.71	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	22.70	3.41	4.92
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	18.25	4.89	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	16.12	3.05	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	16.28	1.81	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	12.35	3.53	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	28.59	1.99	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	25.30	3.97	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	17.23	1.91	1.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	37.50	6.05	5.75
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	23.43	3.09	3.54
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	16.26	4.74	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	81.75	10.22	20.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	27.44	4.88	2.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	16.37	4.09	2.20
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	18.76	2.42	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.15	3.16	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	19.27	1.13	9.07
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	10.12	0.00
Myoblast, donor1	11241-116D8	56.15	7.58	5.47
Myoblast, donor2	11322-117D8	44.49	7.48	3.84
Myoblast, donor3	11398-118D3	51.63	8.91	3.53
NK T cell leukemia cell line:KHYG-1	10777-110G3	60.85	7.44	5.55
Natural Killer Cells, donor1	11230-116C6	88.56	10.15	3.08
Natural Killer Cells, donor2	11311-117C6	58.20	13.57	3.32
Natural Killer Cells, donor3	11387-118C1	65.89	13.80	3.68
Neural stem cells, donor1	11275-116H6	55.17	5.44	5.44
Neural stem cells, donor2	11352-117H2	32.74	3.85	9.63
Neurons, donor1	11494-119E9	35.27	10.24	7.97
Neurons, donor2	11574-120E8	63.85	9.69	10.13
Neurons, donor3	11655-122E8	40.29	4.93	9.04
Neutrophils, donor1	11233-116C9	23.20	1.86	2.78
Neutrophils, donor2	11314-117C9	8.70	0.00	2.90
Neutrophils, donor3	11390-118C4	20.16	2.44	4.28
Nucleus Pulposus Cell, donor1	11252-116F1	42.27	4.63	4.39
Nucleus Pulposus Cell, donor2	11409-118E5	29.30	3.91	3.91
Nucleus Pulposus Cell, donor3	11462-119B4	25.67	3.61	4.01
Olfactory epithelial cells, donor1	11933-125I7	25.60	4.68	1.51
Olfactory epithelial cells, donor2	11934-125I8	29.53	5.65	3.04
Olfactory epithelial cells, donor3	11935-125I9	25.54	4.31	2.27
Olfactory epithelial cells, donor4	11936-126A1	30.49	3.80	5.16
Oligodendrocyte - precursors, donor1	11496-119F2	42.73	4.21	2.41
Osteoblast - differentiated, donor1	11276-116H7	38.92	5.53	5.53
Osteoblast - differentiated, donor2	11353-117H3	17.15	6.86	3.43
Osteoblast - differentiated, donor3	11425-118G3	18.62	2.48	4.97
Osteoblast, donor1	11277-116H8	79.54	14.07	10.55
Osteoblast, donor2	11354-117H4	74.45	14.75	6.32
Osteoblast, donor3	11426-118G4	53.32	10.13	7.82
Pancreatic stromal cells, donor1	11249-116E7	48.10	5.48	5.31
Pericytes, donor1	11491-119E6	19.58	2.78	3.56
Pericytes, donor2	11571-120E5	21.96	1.36	2.04
Pericytes, donor3	11652-122E5	41.50	7.12	5.09
Perineurial Cells, donor1	11499-119F5	55.15	5.65	7.91
Perineurial Cells, donor2	11579-120F4	45.82	6.16	5.61
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	103.91	10.52	2.87
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	48.97	6.61	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	50.60	4.66	1.68
Placental Epithelial Cells, donor1	11278-116H9	57.64	4.07	4.78
Placental Epithelial Cells, donor2	11355-117H5	44.36	9.98	3.33
Placental Epithelial Cells, donor3	11427-118G5	28.07	3.34	3.73
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	25.63	6.96	2.22
Preadipocyte - breast, donor1	11467-119B9	60.03	8.07	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	57.82	9.92	5.22
Preadipocyte - breast, donor2	11328-117E5	40.75	7.88	2.70
Preadipocyte - omental, donor1	11468-119C1	41.98	5.86	3.30
Preadipocyte - omental, donor2	11329-117E6	40.16	7.86	2.18
Preadipocyte - omental, donor3	11403-118D8	45.55	10.31	2.58
Preadipocyte - perirenal, donor1	11469-119C2	34.45	14.76	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	74.02	17.20	5.53
Preadipocyte - subcutaneous, donor2	11356-117H6	57.37	10.80	7.08
Preadipocyte - subcutaneous, donor3	11428-118G6	48.02	9.37	4.60
Preadipocyte - visceral, donor1	11280-116I2	79.36	10.90	7.36
Preadipocyte - visceral, donor2	11357-117H7	43.26	7.36	2.76
Preadipocyte - visceral, donor3	11429-118G7	44.51	6.69	4.08
Prostate Epithelial Cells (polarized), donor1	11253-116F2	70.45	12.52	3.62
Prostate Epithelial Cells, donor2	11331-117E8	21.40	2.98	2.03
Prostate Epithelial Cells, donor3	11404-118D9	13.04	1.53	4.35
Prostate Stromal Cells, donor1	11254-116F3	56.84	8.77	6.04
Prostate Stromal Cells, donor2	11332-117E9	37.83	5.56	4.48
Prostate Stromal Cells, donor3	11405-118E1	28.26	3.55	2.40
Renal Cortical Epithelial Cells, donor1	11516-119H4	48.54	6.20	4.01
Renal Cortical Epithelial Cells, donor2	11596-120H3	40.76	4.23	3.05
Renal Epithelial Cells, donor1	11517-119H5	26.38	5.07	3.04
Renal Epithelial Cells, donor2	11597-120H4	38.41	4.98	1.42
Renal Epithelial Cells, donor3	11678-122H4	47.00	2.12	2.43
Renal Glomerular Endothelial Cells, donor1	11514-119H2	22.47	6.81	3.40
Renal Glomerular Endothelial Cells, donor2	11594-120H1	48.25	6.33	4.99
Renal Glomerular Endothelial Cells, donor3	11675-122H1	39.74	5.77	3.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.32	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	48.64	6.60	5.06
Renal Mesangial Cells, donor2	11598-120H5	60.82	7.52	2.51
Renal Mesangial Cells, donor3	11679-122H5	20.53	3.33	2.77
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	77.84	9.93	6.98
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	30.78	3.80	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	51.88	7.52	4.24
Retinal Pigment Epithelial Cells, donor0	11215-116A9	46.41	7.00	6.22
Retinal Pigment Epithelial Cells, donor1	11528-119I7	55.43	7.11	3.70
Retinal Pigment Epithelial Cells, donor2	11608-120I6	33.96	3.09	4.12
Retinal Pigment Epithelial Cells, donor3	11689-122I6	45.67	3.01	5.27
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	42.50	4.68	3.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	32.16	9.83	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	53.39	7.15	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	38.28	6.96	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	46.03	7.41	3.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	38.03	7.85	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	67.59	9.82	3.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	52.59	7.19	5.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	40.32	6.76	3.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	59.63	7.63	3.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	35.32	6.02	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	35.40	3.18	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	58.42	9.14	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	41.60	7.32	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	40.99	6.98	3.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	43.59	10.84	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	36.32	6.69	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	34.38	5.96	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	76.67	10.52	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	29.59	5.44	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	36.11	5.74	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	51.18	6.49	3.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	30.86	4.16	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	44.85	6.73	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	50.42	7.86	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	31.73	2.92	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	39.98	5.89	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	51.58	7.66	4.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	50.71	5.66	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	39.88	7.34	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	49.34	8.42	3.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	41.47	7.88	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	54.20	7.74	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	50.55	6.48	3.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	43.34	7.13	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	36.44	7.15	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	43.76	7.90	4.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	37.31	7.22	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	33.06	7.96	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	44.00	6.73	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	36.13	4.94	3.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	44.39	9.17	3.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	37.85	8.53	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	30.56	5.39	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	42.38	7.14	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	34.26	7.05	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	32.40	7.44	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	38.78	5.24	3.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	25.69	5.44	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	36.96	5.75	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	82.24	10.48	5.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	28.60	11.56	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	47.62	5.12	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	40.26	6.79	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	44.33	6.29	4.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	54.43	7.20	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	40.34	11.31	4.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	42.07	7.21	7.81
Schwann Cells, donor1	11498-119F4	32.72	8.09	6.39
Schwann Cells, donor2	11578-120F3	47.63	0.00	6.80
Schwann Cells, donor3	11659-122F3	40.75	5.48	6.79
Sebocyte, donor1	11220-116B5	45.46	4.38	6.03
Sebocyte, donor2	11301-117B5	20.68	1.84	1.38
Sebocyte, donor3	11378-118B1	22.05	3.09	2.06
Sertoli Cells, donor1	11255-116F4	56.32	8.28	3.31
Sertoli Cells, donor2	11333-117F1	48.01	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	38.09	3.52	5.45
Skeletal Muscle Cells, donor2	11358-117H8	18.79	4.34	2.17
Skeletal Muscle Cells, donor3	11430-118G8	39.29	8.36	1.67
Skeletal Muscle Cells, donor4	11451-119A2	55.77	8.01	6.28
Skeletal Muscle Cells, donor5	11455-119A6	55.30	8.92	8.03
Skeletal Muscle Cells, donor6	11459-119B1	56.02	9.54	7.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	72.08	8.44	5.67
Skeletal Muscle Satellite Cells, donor2	11321-117D7	53.08	7.71	7.13
Skeletal Muscle Satellite Cells, donor3	11397-118D2	56.55	9.62	7.24
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	54.09	7.58	3.88
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	38.36	4.34	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	44.44	8.53	3.16
Skin - palm, donor1	10286-104F7	40.29	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	17.15	3.32	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	95.69	18.81	7.36
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.02	2.60	1.43
Small Airway Epithelial Cells, donor1	11256-116F5	43.65	5.14	3.61
Small Airway Epithelial Cells, donor2	11334-117F2	20.25	3.38	2.67
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	89.86	12.05	4.23
Small Airway Epithelial Cells, donor3	11406-118E2	15.29	1.95	3.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	36.41	7.71	4.32
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	29.79	3.56	2.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	39.38	9.99	4.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	38.67	3.98	1.55
Smooth Muscle Cells - Aortic, donor2	11360-117I1	38.20	7.48	2.76
Smooth Muscle Cells - Aortic, donor3	11432-118H1	54.85	6.18	4.64
Smooth Muscle Cells - Bladder, donor1	11519-119H7	36.03	7.01	5.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	44.18	6.65	2.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	41.45	7.76	3.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	48.91	11.14	6.79
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	55.02	8.14	6.51
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	63.79	7.38	6.20
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	34.88	5.69	4.84
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	37.90	6.02	5.37
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.31	2.44	5.18
Smooth Muscle Cells - Carotid, donor1	11285-116I7	49.00	6.82	4.04
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	12.24
Smooth Muscle Cells - Carotid, donor3	11434-118H3	24.80	3.34	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	46.90	4.57	4.72
Smooth Muscle Cells - Colonic, donor2	11320-117D6	35.30	4.95	4.09
Smooth Muscle Cells - Colonic, donor3	11396-118D1	37.26	7.03	4.93
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	49.03	4.33	3.87
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	43.12	10.78	8.62
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	30.48	5.98	4.78
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	35.85	3.76	4.78
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	41.46	2.98	3.14
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	55.96	6.44	4.83
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	38.91	5.92	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	35.62	4.23	3.62
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	61.99	11.92	12.19
Smooth Muscle Cells - Prostate, donor1	11257-116F6	41.95	6.13	5.59
Smooth Muscle Cells - Prostate, donor2	11335-117F3	30.05	6.14	4.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	31.71	3.55	4.06
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	63.17	11.16	5.28
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	23.26	6.00	3.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	32.31	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	46.97	9.77	2.79
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	37.36	7.57	4.54
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	34.47	5.33	3.45
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	36.58	6.78	3.83
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	63.48	7.50	10.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	30.83	4.67	7.01
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	47.06	7.77	4.17
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	38.24	7.14	5.61
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	41.37	5.83	3.95
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	52.82	6.15	5.45
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	47.34	5.78	4.69
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	12.38	1.43	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	32.05	5.63	3.67
Smooth Muscle Cells - Uterine, donor1	11258-116F7	39.77	4.86	3.98
Smooth Muscle Cells - Uterine, donor3	11466-119B8	34.82	3.80	5.27
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	26.04	2.92	2.33
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	17.72	1.85	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	34.59	5.58	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	30.54	5.75	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	30.09	3.69	1.42
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	32.69	3.15	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	27.43	2.79	2.29
Smooth muscle cells - airway, control, donor2	11967-126D5	24.76	1.60	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	30.10	3.76	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	25.67	2.29	0.92
Synoviocyte, donor1	11291-117A4	44.10	5.55	3.20
Synoviocyte, donor2	11368-117I9	29.50	4.53	3.69
Synoviocyte, donor3	11440-118H9	28.15	5.14	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	74.32	6.43	4.29
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	17.83	2.78	3.47
Tracheal Epithelial Cells, donor1	11292-117A5	33.62	2.44	3.08
Tracheal Epithelial Cells, donor2	11369-118A1	27.06	5.03	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	23.48	3.44	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	45.40	4.67	3.57
Urethra, donor2	10319-105A4	37.77	1.80	5.40
Urothelial Cells, donor1	11520-119H8	30.55	4.52	1.59
Urothelial Cells, donor2	11600-120H7	22.43	3.20	2.00
Urothelial Cells, donor3	11681-122H7	20.40	2.75	2.75
Urothelial cells, donor0	11216-116B1	39.01	4.24	2.23
Whole blood (ribopure), donor090309, donation1	12179-129A1	92.54	18.69	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	87.21	11.44	7.15
Whole blood (ribopure), donor090309, donation3	12181-129A3	44.49	10.95	3.42
Whole blood (ribopure), donor090325, donation1	12176-128I7	79.89	8.61	3.44
Whole blood (ribopure), donor090325, donation2	12177-128I8	83.67	6.39	2.91
Whole blood (ribopure), donor090612, donation1	12182-129A4	67.68	11.45	9.37
Whole blood (ribopure), donor090612, donation2	12183-129A5	77.09	14.68	6.42
Whole blood (ribopure), donor090612, donation3	12184-129A6	43.82	11.87	2.74
Wilms' tumor cell line:G-401	10809-111A8	39.85	7.77	4.07
Wilms' tumor cell line:HFWT	10597-108E3	14.96	3.52	3.52
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	58.66	8.66	5.31
achilles tendon, donor2	10292-104G4	39.26	10.33	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	88.47	13.00	4.08
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	150.45	19.04	7.20
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	130.22	13.06	6.05
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	60.68	11.43	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	94.44	12.93	4.22
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	133.23	33.41	2.96
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	73.22	10.62	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	131.31	24.68	5.73
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	107.81	24.91	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	132.02	35.34	5.44
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	99.54	17.66	5.15
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	46.81	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	92.49	25.79	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	132.56	24.85	3.11
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	108.42	21.04	2.34
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	56.70	12.08	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	82.25	15.22	3.70
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	34.69	8.90	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	92.60	19.20	3.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	107.97	17.29	3.03
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	119.63	24.07	3.85
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	77.07	16.04	3.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	44.36	8.34	2.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	66.90	11.15	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	87.01	24.48	4.90
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	62.37	20.93	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	58.11	18.74	0.00
adenocarcinoma cell line:IM95m	10796-110I4	48.04	12.48	3.53
adipose tissue, adult, pool1	10010-101C1	37.69	4.96	2.17
adipose, donor1	10184-103D4	52.19	7.04	9.38
adipose, donor2	10185-103D5	21.90	2.43	2.03
adipose, donor3	10186-103D6	31.31	3.00	3.54
adipose, donor4	10187-103D7	36.40	7.80	4.33
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	41.66	9.94	5.37
adrenal gland, adult, pool1	10081-102A9	43.65	0.00	10.91
adult T-cell leukemia cell line:ATN-1	10421-106C7	42.56	6.27	3.74
alveolar cell carcinoma cell line:SW 1573	10708-109H6	40.02	6.43	5.72
amniotic membrane cells, donor1	12235-129G3	49.38	6.49	2.78
amniotic membrane cells, donor2	12236-129G4	70.33	11.16	7.78
amniotic membrane cells, donor3	12237-129G5	44.78	4.12	5.01
amygdala - adult, donor10196	10167-103B5	30.83	20.16	2.37
amygdala, adult, donor10252	10151-102I7	51.50	9.33	7.30
amygdala, newborn, donor10223	10360-105E9	28.40	4.84	3.55
anaplastic carcinoma cell line:8305C	10428-106D5	52.71	3.57	6.88
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	49.86	7.72	4.85
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	66.14	7.35	10.69
aorta, adult, pool1	10052-101G7	35.11	6.08	3.53
appendix, adult	10189-103D9	55.89	5.82	8.15
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	141.70	20.64	3.10
artery, adult	10190-103E1	48.91	5.43	9.51
astrocytoma cell line:TM-31	10425-106D2	45.20	6.66	3.19
b cell line:RPMI1788	10427-106D4	69.89	10.11	7.29
basal cell carcinoma cell line:TE 354.T	10702-109G9	49.66	9.71	3.33
bile duct carcinoma cell line:HuCCT1	10432-106D9	48.13	6.55	3.67
bile duct carcinoma cell line:TFK-1	10496-107C1	32.47	5.02	4.18
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	58.72	17.90	1.12
bladder, adult, pool1	10011-101C2	20.86	1.74	1.96
blood, adult, pool1	10053-101G8	35.43	17.72	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	38.54	2.57	2.57
bone marrow, adult	10192-103E3	43.19	3.37	3.37
brain, adult, donor1	10084-102B3	38.95	11.28	4.10
brain, adult, pool1	10012-101C3	39.31	10.58	4.90
brain, fetal, pool1	10085-102B4	45.41	8.01	10.69
breast carcinoma cell line:MCF7	10482-107A5	42.62	6.28	2.97
breast carcinoma cell line:MDA-MB-453	10419-106C5	66.16	6.74	3.50
breast, adult, donor1	10080-102A8	26.52	0.00	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	59.71	7.88	3.81
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	38.03	4.95	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	102.45	16.58	6.45
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	41.64	6.78	3.87
carcinoid cell line:NCI-H1770	10703-109H1	56.42	10.34	4.70
carcinoid cell line:NCI-H727	10735-110B6	46.27	9.30	3.94
carcinoid cell line:SK-PN-DW	10719-109I8	63.38	6.65	4.12
carcinosarcoma cell line:JHUCS-1	10642-109A3	68.41	11.71	11.45
caudate nucleus - adult, donor10196	10177-103C6	37.99	21.88	5.76
caudate nucleus, adult, donor10252	10164-103B2	51.70	8.87	7.86
caudate nucleus, adult, donor10258	10379-105H1	54.25	16.81	3.82
caudate nucleus, newborn, donor10223	10354-105E3	40.29	4.39	5.49
cerebellum - adult, donor10196	10173-103C2	49.53	14.57	11.65
cerebellum, adult, donor10252	10166-103B4	64.69	6.41	19.43
cerebellum, adult, pool1	10083-102B2	34.84	6.55	9.31
cerebellum, newborn, donor10223	10357-105E6	110.43	9.13	14.95
cerebral meninges, adult	10188-103D8	36.31	8.57	4.79
cerebrospinal fluid, donor2	10294-104G6	27.77	5.85	2.19
cervical cancer cell line:D98-AH2	10552-107I3	57.23	7.62	6.90
cervical cancer cell line:ME-180	10553-107I4	28.34	2.15	4.14
cervix, adult, pool1	10013-101C4	44.31	5.35	5.56
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	43.75	4.74	5.29
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	1.31	1.31
choriocarcinoma cell line:BeWo	10423-106C9	89.85	9.20	5.97
choriocarcinoma cell line:SCH	10785-110H2	31.42	3.70	3.20
choriocarcinoma cell line:T3M-3	10618-108G6	28.70	5.22	3.32
chorionic membrane cells, donor1	12238-129G6	38.18	4.27	3.42
chorionic membrane cells, donor2	12239-129G7	52.50	7.95	4.57
chorionic membrane cells, donor3	12240-129G8	39.56	2.20	4.95
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	93.91	21.21	6.06
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	70.12	15.75	2.31
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	59.34	11.40	2.96
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	70.11	11.30	5.65
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	63.61	13.79	4.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	68.01	10.99	4.07
chronic myelogenous leukemia cell line:K562	10454-106G4	143.40	16.78	7.66
chronic myelogenous leukemia cell line:KU812	10409-106B4	85.49	15.64	2.61
clear cell carcinoma cell line:JHOC-5	10638-108I8	36.12	5.26	4.57
clear cell carcinoma cell line:TEN	10636-108I6	53.79	5.21	4.34
colon carcinoma cell line:CACO-2	10513-107D9	69.01	12.45	1.65
colon carcinoma cell line:COLO-320	10420-106C6	140.63	19.76	7.22
colon, adult, donor1	10082-102B1	49.98	5.95	4.76
colon, adult, pool1	10014-101C5	37.37	4.47	4.11
colon, fetal, donor1	10070-101I7	34.61	1.24	1.85
common myeloid progenitor CMP, donor1	12130-128D6	220.01	36.67	4.58
common myeloid progenitor CMP, donor2	12134-128E1	175.26	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	67.56	4.25	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	66.11	7.70	3.92
cord blood derived cell line:COBL-a untreated	10449-106F8	72.34	7.61	2.68
corpus callosum, adult, pool1	10042-101F6	136.66	28.75	11.50
cruciate ligament, donor2	10295-104G7	53.49	2.43	2.43
diaphragm, fetal, donor1	10069-101I6	36.92	4.82	8.03
diencephalon, adult	10193-103E4	47.52	10.56	7.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	197.01	31.92	8.27
ductal cell carcinoma cell line:KLM-1	10438-106E6	71.55	7.18	4.62
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	59.94	8.43	4.57
ductus deferens, adult	10196-103E7	42.36	3.99	5.48
duodenum, fetal, donor1, tech_rep1	10071-101I8	64.81	8.64	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	73.56	8.09	4.41
dura mater, adult, donor1	10041-101F5	58.64	9.00	5.29
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	109.70	7.55	7.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	110.91	6.59	7.74
embryonic pancreas cell line:1B2C6	10604-108F1	35.76	4.93	3.70
embryonic pancreas cell line:1C3D3	10605-108F2	37.84	4.54	7.27
embryonic pancreas cell line:1C3IKEI	10606-108F3	30.87	3.70	2.78
embryonic pancreas cell line:2C6	10603-108E9	32.84	5.25	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	58.66	4.36	7.71
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	54.37	3.99	6.16
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	49.21	7.72	3.70
epidermoid carcinoma cell line:A431	10426-106D3	33.57	4.89	3.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	64.45	7.48	6.38
epididymis, adult	10197-103E8	55.68	6.91	4.19
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	94.20	17.39	4.97
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	21.24	1.97	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	93.44	12.97	5.37
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	65.25	11.32	4.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	93.43	12.44	6.72
esophagus, adult, pool1	10015-101C6	34.30	3.72	3.50
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	46.84	3.76	4.13
eye - muscle inferior rectus, donor1	10272-104E2	38.63	0.00	7.24
eye - muscle lateral, donor2	10298-104H1	33.67	2.10	0.00
eye - muscle medial, donor2	10299-104H2	44.65	5.95	2.98
eye - muscle superior, donor2	10297-104G9	29.81	3.44	6.88
eye - vitreous humor, donor1	10268-104D7	34.98	4.37	0.00
eye, fetal, donor1	10054-101G9	25.42	3.56	4.83
fibrosarcoma cell line:HT-1080	10758-110E2	34.62	8.08	4.23
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	49.38	5.70	5.70
frontal lobe, adult, pool1	10040-101F4	61.92	19.23	8.35
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	86.47	11.71	4.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	33.47	4.48	6.03
gall bladder, adult	10198-103E9	35.49	3.38	2.17
gamma delta positive T cells, donor1	11937-126A2	112.74	15.03	7.52
gamma delta positive T cells, donor2	11938-126A3	110.93	14.94	5.98
gastric adenocarcinoma cell line:MKN1	10614-108G2	44.36	5.70	6.76
gastric adenocarcinoma cell line:MKN45	10612-108F9	73.50	11.60	5.22
gastric cancer cell line:AZ521	10549-107H9	54.43	7.38	3.77
gastric cancer cell line:GSS	10560-108A2	37.52	7.32	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	20.79	4.11	1.83
giant cell carcinoma cell line:LU65	10487-107B1	39.36	3.33	7.57
giant cell carcinoma cell line:Lu99B	10433-106E1	141.22	11.76	18.33
glassy cell carcinoma cell line:HOKUG	10688-109F4	39.91	7.48	3.49
glioblastoma cell line:A172, tech_rep1	10444-106F3	33.25	4.96	2.64
glioblastoma cell line:A172, tech_rep2	10444-106F3	25.14	3.79	3.65
glioblastoma cell line:T98G	10485-107A8	49.01	3.86	4.97
glioma cell line:GI-1	10413-106B8	34.56	4.69	2.34
globus pallidus - adult, donor10196	10175-103C4	55.40	19.68	3.64
globus pallidus, adult, donor10252	10161-103A8	90.80	18.31	12.69
globus pallidus, adult, donor10258	10367-105F7	102.69	26.01	9.58
globus pallidus, newborn, donor10223	10364-105F4	48.50	6.93	3.73
granulocyte macrophage progenitor, donor1	12131-128D7	181.09	44.05	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	78.40	5.23	10.45
granulosa cell tumor cell line:KGN	10624-108H3	35.52	4.48	4.48
hIPS +CCl2, biol_rep1	14383-156B9	56.93	9.64	4.59
hIPS +CCl2, biol_rep2	14384-156C1	58.07	17.38	3.20
hIPS +CCl2, biol_rep3	14385-156C2	59.26	15.46	5.15
hIPS, biol_rep1	14380-156B6	54.62	20.12	1.44
hIPS, biol_rep2	14381-156B7	44.58	17.83	4.80
hIPS, biol_rep3	14382-156B8	45.24	12.14	5.52
hairy cell leukemia cell line:Mo	10712-109I1	65.80	9.77	2.30
heart - mitral valve, adult	10205-103F7	43.35	5.08	3.29
heart - pulmonic valve, adult	10206-103F8	31.90	3.40	4.71
heart - tricuspid valve, adult	10207-103F9	37.47	6.66	4.16
heart, adult, diseased post-infarction, donor1	10050-101G5	29.18	4.90	4.49
heart, adult, diseased, donor1	10051-101G6	40.88	6.81	7.66
heart, adult, pool1	10016-101C7	25.07	1.84	3.68
heart, fetal, pool1	10046-101G1	55.24	4.52	6.37
hepatic mesenchymal tumor cell line:LI90	10778-110G4	33.94	7.10	4.32
hepatoblastoma cell line:HuH-6	10633-108I3	47.57	2.38	4.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	59.67	9.28	2.98
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	60.81	12.87	3.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	67.91	12.03	3.13
hepatoma cell line:Li-7	10484-107A7	80.41	6.34	6.45
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	69.65	13.17	6.43
hippocampus - adult, donor10196	10169-103B7	34.07	9.46	3.79
hippocampus, adult, donor10252	10153-102I9	58.78	9.18	6.33
hippocampus, adult, donor10258	10374-105G5	38.34	20.91	4.48
hippocampus, newborn, donor10223	10363-105F3	37.01	3.88	3.88
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	75.68	10.38	7.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	44.38	4.71	6.09
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	47.73	6.09	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	43.42	2.26	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	44.15	4.39	4.91
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	55.80	7.21	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	46.13	4.67	7.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	32.75	4.09	6.68
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	48.38	3.75	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	57.78	5.68	6.39
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	40.34	5.14	4.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	61.27	5.39	6.06
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	39.43	4.69	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	41.27	5.40	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	66.33	6.11	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	37.61	3.44	4.39
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	35.32	3.92	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	39.48	3.50	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	27.13	2.07	4.71
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	29.10	2.27	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	35.40	2.19	5.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	29.56	2.94	3.59
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	27.87	4.64	3.77
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	29.59	3.59	4.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	56.16	5.91	4.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	51.92	5.14	4.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	77.58	13.07	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	48.59	7.04	4.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	51.31	5.70	3.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	52.35	6.36	4.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	35.68	1.55	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	33.21	2.66	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	42.33	5.90	4.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	39.63	4.60	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	43.92	6.06	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	35.96	3.36	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	47.34	6.52	7.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	56.15	8.02	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	55.12	2.93	4.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	50.73	4.89	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	201.70	9.76	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	74.46	7.61	5.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	42.69	6.02	4.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	41.62	5.07	5.43
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	36.65	3.91	2.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	31.03	5.97	4.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	52.00	4.88	7.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	24.78	4.58	3.77
immature langerhans cells, donor1	11904-125F5	23.73	5.33	0.73
immature langerhans cells, donor2	11905-125F6	44.36	9.51	1.58
insula, adult, pool1	10039-101F3	80.25	16.47	8.61
keratoacanthoma cell line:HKA-1	10791-110H8	29.59	8.45	0.98
kidney, adult, pool1	10017-101C8	44.56	4.61	2.90
kidney, fetal, pool1	10045-101F9	61.68	5.16	6.22
large cell lung carcinoma cell line:IA-LM	10509-107D5	107.94	16.19	5.96
large cell lung carcinoma cell line:NCI-H460	10839-111E2	38.57	6.91	2.63
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	25.87	2.94	7.89
left atrium, adult, donor1	10079-102A7	16.89	3.27	2.72
left ventricle, adult, donor1	10078-102A6	22.25	4.55	2.53
leiomyoblastoma cell line:G-402	10721-110A1	36.94	8.21	4.65
leiomyoma cell line:10964C	10569-108B2	34.49	2.51	3.95
leiomyoma cell line:15242A	10570-108B3	29.89	5.43	3.26
leiomyoma cell line:15425	10571-108B4	32.29	3.64	3.64
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	33.46	4.18	4.18
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	76.86	19.36	2.72
liposarcoma cell line:KMLS-1	10782-110G8	53.74	10.47	4.69
liposarcoma cell line:SW 872	10726-110A6	33.14	4.02	3.66
liver, adult, pool1	10018-101C9	48.13	4.21	5.35
liver, fetal, pool1	10086-102B5	31.04	4.70	0.00
locus coeruleus - adult, donor10196	10182-103D2	33.69	8.02	4.37
locus coeruleus, adult, donor10252	10165-103B3	68.28	8.67	9.60
locus coeruleus, adult, donor10258	10375-105G6	46.27	10.16	3.95
locus coeruleus, newborn, donor10223	10362-105F2	37.01	6.31	4.63
lung adenocarcinoma cell line:A549	10499-107C4	29.75	3.18	2.91
lung adenocarcinoma cell line:PC-14	10408-106B3	24.82	3.45	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	37.96	6.72	1.45
lung, adult, pool1	10019-101D1	24.33	2.95	3.78
lung, fetal, donor1	10068-101I5	81.06	10.27	7.71
lung, right lower lobe, adult, donor1	10075-102A3	45.36	5.04	4.58
lymph node, adult, donor1	10077-102A5	25.09	5.21	3.79
lymphangiectasia cell line:DS-1	10727-110A7	96.44	21.04	5.70
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	109.72	15.24	5.28
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	58.62	5.10	8.49
mature adipocyte, donor1	12231-129F8	55.05	10.66	5.77
mature adipocyte, donor2	12232-129F9	44.41	5.40	6.02
mature adipocyte, donor3	12233-129G1	48.12	6.16	6.16
mature adipocyte, donor4	12234-129G2	45.80	3.69	7.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	80.29	13.10	9.05
medial frontal gyrus - adult, donor10196	10170-103B8	42.87	10.15	5.64
medial frontal gyrus, adult, donor10252	10150-102I6	56.64	8.28	8.09
medial frontal gyrus, adult, donor10258	10368-105F8	44.79	11.44	6.04
medial frontal gyrus, newborn, donor10223	10352-105E1	42.65	9.81	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	44.38	14.85	7.09
medial temporal gyrus, adult, donor10252	10156-103A3	62.82	8.91	9.34
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	59.71	21.19	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	14.35	43.06
medial temporal gyrus, newborn, donor10223	10353-105E2	35.53	9.69	3.23
medulla oblongata - adult, donor10196	10174-103C3	49.32	14.28	3.89
medulla oblongata, adult, donor10252	10155-103A2	68.73	10.37	7.89
medulla oblongata, adult, pool1	10038-101F2	61.55	12.24	6.69
medulla oblongata, newborn, donor10223	10361-105F1	46.52	6.60	3.82
medulloblastoma cell line:D283 Med	10838-111E1	77.72	14.61	10.41
medulloblastoma cell line:ONS-76	10759-110E3	31.67	5.50	3.42
melanoma cell line:COLO 679	10514-107E1	50.89	8.91	3.59
melanoma cell line:G-361	10465-106H6	42.89	2.71	6.79
meningioma cell line:HKBMM	10691-109F7	33.29	3.08	2.35
merkel cell carcinoma cell line:MKL-1	10843-111E6	138.34	25.55	7.05
merkel cell carcinoma cell line:MS-1	10844-111E7	126.50	18.92	6.48
mesenchymal precursor cell - adipose, donor1	11747-123G1	59.53	10.89	5.68
mesenchymal precursor cell - adipose, donor2	11748-123G2	34.54	5.45	2.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	48.04	7.45	4.56
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	35.40	5.06	4.21
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	42.94	4.43	4.81
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	43.73	4.86	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	24.37	3.78	2.75
mesenchymal precursor cell - cardiac, donor2	11753-123G7	32.78	5.41	4.03
mesenchymal precursor cell - cardiac, donor3	11754-123G8	46.95	9.55	5.17
mesenchymal precursor cell - cardiac, donor4	11755-123G9	41.59	6.89	5.94
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	38.41	7.82	2.70
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	28.65	3.62	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	39.30	7.06	3.60
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	57.60	6.63	3.84
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	36.14	4.90	6.33
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	37.02	5.03	2.88
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.31	3.21	3.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	36.25	4.10	1.60
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	54.54	4.20	7.97
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	39.60	7.17	5.23
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	33.44	4.11	4.38
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	37.92	5.89	6.26
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	41.78	5.15	5.44
mesenchymal stem cell line:Hu5/E18	10568-108B1	45.05	5.05	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	34.25	5.48	2.74
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	36.58	6.65	3.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	36.12	8.38	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	35.12	7.09	3.08
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	33.89	6.12	3.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	45.69	7.78	3.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	41.66	5.11	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	37.07	5.10	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	193.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	55.95	7.50	4.61
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	41.27	8.03	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	41.10	8.89	5.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	29.33	6.60	3.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	48.00	5.03	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	42.58	9.01	3.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	45.10	8.59	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	2.73	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	15.49	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	39.95	8.77	2.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	37.83	13.09	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	42.11	6.40	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	43.34	3.27	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	41.20	9.33	3.50
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	31.48	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	47.69	7.95	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	49.22	5.34	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	42.65	6.09	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	45.60	7.60	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	44.15	5.86	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	40.83	12.90	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	48.21	13.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	40.34	7.74	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	38.93	11.12	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	34.19	7.66	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	37.09	4.99	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	33.42	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	34.30	8.28	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	48.88	11.70	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	33.15	5.94	5.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	31.40	8.97	7.85
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	36.89	3.18	5.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	37.07	3.63	4.84
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	63.24	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	26.61	1.27	7.60
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	27.92	6.07	7.28
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	4.52	18.08
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.06	4.94	4.12
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	46.63	5.75	4.17
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	26.28	2.92	2.92
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	31.58	4.07	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	35.59	3.09	3.87
mesothelioma cell line:ACC-MESO-1	10493-107B7	30.48	0.47	5.91
mesothelioma cell line:ACC-MESO-4	10494-107B8	64.87	7.88	3.94
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	51.28	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	44.29	5.55	2.88
mesothelioma cell line:Mero-25	10850-111F4	43.58	8.17	3.40
mesothelioma cell line:Mero-41	10851-111F5	64.30	5.87	4.40
mesothelioma cell line:Mero-48a	10852-111F6	42.96	7.97	6.42
mesothelioma cell line:Mero-82	10853-111F7	32.85	5.78	3.68
mesothelioma cell line:Mero-83	10854-111F8	33.87	5.11	2.89
mesothelioma cell line:Mero-84	10855-111F9	60.16	8.85	2.78
mesothelioma cell line:Mero-95	10856-111G1	54.87	7.45	3.11
mesothelioma cell line:NCI-H2052	10847-111F1	36.28	5.80	3.31
mesothelioma cell line:NCI-H226	10846-111E9	36.74	4.34	2.17
mesothelioma cell line:NCI-H2452	10848-111F2	46.12	7.69	3.76
mesothelioma cell line:NCI-H28	10845-111E8	32.57	4.07	1.78
mesothelioma cell line:No36	10857-111G2	44.36	8.81	2.61
mesothelioma cell line:ONE58	10858-111G3	51.75	4.06	1.90
migratory langerhans cells, donor1	11901-125F2	48.94	4.80	2.49
migratory langerhans cells, donor2	11902-125F3	50.19	3.79	3.79
migratory langerhans cells, donor3	11903-125F4	59.05	6.46	3.41
mixed mullerian tumor cell line:HTMMT	10689-109F5	37.55	3.26	10.45
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	29.67	5.30	7.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	17.51	1.84	1.15
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	34.06	7.80	3.04
myelodysplastic syndrome cell line:SKM-1	10772-110F7	81.12	10.90	7.02
myeloma cell line:PCM6	10474-106I6	47.04	7.31	3.16
myxofibrosarcoma cell line:MFH-ino	10600-108E6	32.47	6.09	2.54
myxofibrosarcoma cell line:NMFH-1	10684-109E9	41.78	9.81	7.06
nasal epithelial cells, donor1, tech_rep1	12226-129F3	23.73	1.89	7.80
nasal epithelial cells, donor1, tech_rep2	12226-129F3	24.19	1.76	7.13
nasal epithelial cells, donor2	12227-129F4	29.81	3.86	4.97
neuroblastoma cell line:CHP-134	10508-107D4	64.65	9.20	5.98
neuroblastoma cell line:NB-1	10539-107G8	128.34	28.44	7.11
neuroblastoma cell line:NBsusSR	10607-108F4	62.63	7.80	10.54
neuroblastoma cell line:NH-12	10555-107I6	79.94	13.04	8.20
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	57.17	8.78	3.32
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	77.92	10.77	9.34
neuroectodermal tumor cell line:TASK1	10774-110F9	66.62	10.47	5.84
neuroepithelioma cell line:SK-N-MC	10728-110A8	57.85	5.09	3.18
neurofibroma cell line:Hs 53.T	10729-110A9	35.40	7.19	1.60
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	9.47	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	220.19	26.55	8.12
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	122.48	23.21	9.61
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	41.36	10.58	7.69
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	45.46	6.04	4.47
nucleus accumbens, adult, pool1	10037-101F1	79.02	17.90	6.47
occipital cortex - adult, donor10196	10172-103C1	57.69	32.97	0.00
occipital cortex, adult, donor10252	10163-103B1	80.24	10.47	7.78
occipital cortex, newborn, donor10223	10355-105E4	34.57	6.91	1.82
occipital lobe, adult, donor1	10076-102A4	45.13	8.92	7.35
occipital lobe, fetal, donor1	10073-102A1	61.79	14.16	8.15
occipital pole, adult, pool1	10036-101E9	54.32	14.98	4.49
olfactory region, adult	10195-103E6	41.84	9.55	6.11
optic nerve, donor1	10277-104E7	80.04	14.01	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	90.22	11.28	4.90
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	74.19	9.34	10.17
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	55.20	4.23	3.22
oral squamous cell carcinoma cell line:SAS	10544-107H4	39.27	7.51	5.66
osteoclastoma cell line:Hs 706.T	10704-109H2	28.81	4.12	3.23
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	36.44	7.47	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	70.19	9.54	4.24
ovary, adult, pool1	10020-101D2	28.13	2.45	5.77
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	35.75	6.23	2.02
pancreas, adult, donor1	10049-101G4	66.79	10.35	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	29.91	4.75	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	32.20	3.58	5.11
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	36.10	3.97	3.48
paracentral gyrus, adult, pool1	10035-101E8	69.19	16.75	7.60
parietal cortex, adult, donor10258	10373-105G4	57.99	9.54	2.94
parietal lobe - adult, donor10196	10171-103B9	36.68	12.23	4.70
parietal lobe, adult, donor10252	10157-103A4	59.57	9.41	6.56
parietal lobe, adult, pool1	10034-101E7	78.60	17.01	6.79
parietal lobe, fetal, donor1	10072-101I9	67.89	13.58	11.64
parietal lobe, newborn, donor10223	10356-105E5	39.63	4.86	2.62
parotid gland, adult	10199-103F1	61.67	13.57	6.17
penis, adult	10200-103F2	39.75	9.13	5.91
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	58.76	4.09	5.39
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	48.22	5.39	5.10
pineal gland - adult, donor10196	10179-103C8	17.42	4.52	3.23
pineal gland, adult, donor10252	10160-103A7	57.44	6.51	6.51
pineal gland, adult, donor10258	10377-105G8	31.35	6.90	1.25
pituitary gland - adult, donor10196	10180-103C9	72.85	13.15	7.08
pituitary gland, adult, donor10252	10162-103A9	125.60	14.59	11.99
pituitary gland, adult, donor10258	10378-105G9	85.98	17.88	2.55
placenta, adult, pool1	10021-101D3	38.59	4.73	2.69
plasma cell leukemia cell line:ARH-77	10840-111E3	49.79	6.49	5.56
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	39.07	5.76	4.82
pons, adult, pool1	10033-101E6	66.27	11.53	5.85
postcentral gyrus, adult, pool1	10032-101E5	65.99	16.04	7.58
promyelocytes/myelocytes PMC, donor1	12132-128D8	52.28	10.46	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	115.67	5.51	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	0.00	23.47
prostate cancer cell line:DU145	10490-107B4	68.02	7.28	8.01
prostate cancer cell line:PC-3	10439-106E7	98.19	13.79	6.35
prostate, adult, pool1	10022-101D4	31.83	3.17	5.08
putamen, adult, donor10196	10176-103C5	35.17	16.05	6.85
putamen, adult, donor10252	10152-102I8	92.15	25.49	7.84
putamen, adult, donor10258, tech_rep1	10372-105G3	39.34	27.32	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	37.21	13.05	3.87
putamen, newborn, donor10223	10365-105F5	42.73	14.99	3.00
rectal cancer cell line:TT1TKB	10469-106I1	32.88	6.40	1.75
rectum, fetal, donor1	10067-101I4	70.94	8.35	6.95
renal cell carcinoma cell line:OS-RC-2	10411-106B6	56.60	5.09	6.36
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	33.14	1.24	2.90
retina, adult, pool1	10030-101E3	54.47	8.05	8.15
retinoblastoma cell line:Y79	10475-106I7	104.18	18.45	10.13
rhabdomyosarcoma cell line:KYM-1	10787-110H4	41.43	7.38	2.34
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	57.65	5.62	4.22
sacrococcigeal teratoma cell line:HTST	10695-109G2	22.74	4.55	3.03
salivary acinar cells, donor1	11771-123I7	32.21	4.53	2.10
salivary acinar cells, donor2	11772-123I8	37.31	6.06	5.09
salivary acinar cells, donor3	11773-123I9	21.85	3.31	2.65
salivary gland, adult, pool1	10093-102C3	107.53	16.01	9.15
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	44.26	3.04	2.95
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	32.91	2.59	4.82
seminal vesicle, adult	10201-103F3	47.62	6.35	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	32.31	6.80	2.92
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	29.44	2.52	5.03
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	72.25	2.01	4.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	51.18	4.03	2.82
signet ring carcinoma cell line:Kato III	10436-106E4	63.66	8.29	5.53
signet ring carcinoma cell line:NUGC-4	10483-107A6	91.87	17.55	3.61
skeletal muscle - soleus muscle, donor1	10282-104F3	22.70	9.93	4.97
skeletal muscle, adult, pool1	10023-101D5	37.78	10.67	6.72
skeletal muscle, fetal, donor1	10066-101I3	26.13	5.03	5.03
skin, adult, donor1	10074-102A2	27.14	6.79	0.00
skin, fetal, donor1	10065-101I2	56.18	12.62	8.21
small cell cervical cancer cell line:HCSC-1	10800-110I8	80.71	12.01	11.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	39.09	4.73	3.15
small cell lung carcinoma cell line:DMS 144	10841-111E4	45.68	5.01	12.14
small cell lung carcinoma cell line:LK-2	10541-107H1	101.86	13.19	7.25
small cell lung carcinoma cell line:NCI-H82	10842-111E5	49.70	6.76	6.43
small cell lung carcinoma cell line:WA-hT	10562-108A4	53.39	10.46	4.14
small intestine, adult, pool1	10024-101D6	53.15	7.64	2.63
small intestine, fetal, donor1	10064-101I1	41.77	7.13	3.69
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	71.29	10.77	4.10
smooth muscle, adult, pool1	10048-101G3	27.14	4.65	5.43
somatostatinoma cell line:QGP-1	10781-110G7	23.05	4.82	1.88
spinal cord - adult, donor10196	10181-103D1	33.49	10.32	3.21
spinal cord, adult, donor10252	10159-103A6	70.97	9.86	9.46
spinal cord, adult, donor10258	10369-105F9	41.51	21.45	8.30
spinal cord, fetal, donor1	10056-101H2	64.03	11.59	6.71
spinal cord, newborn, donor10223	10359-105E8	76.23	13.32	3.67
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	33.01	6.72	2.99
spleen, adult, pool1	10025-101D7	47.47	5.73	3.74
spleen, fetal, pool1	10044-101F8	63.48	7.47	4.69
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	87.99	12.94	4.04
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	41.77	6.46	2.85
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	37.74	3.49	3.15
squamous cell carcinoma cell line:T3M-5	10616-108G4	28.15	5.08	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	120.44	10.81	13.51
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	61.42	9.74	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	34.27	4.65	0.85
stomach, fetal, donor1	10062-101H8	61.94	6.41	7.48
submaxillary gland, adult	10202-103F4	68.93	10.25	3.99
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	119.85	20.15	9.14
substantia nigra, adult, donor10258	10371-105G2	44.48	13.45	2.07
substantia nigra, newborn, donor10223	10358-105E7	51.58	7.07	2.83
synovial sarcoma cell line:HS-SY-II	10441-106E9	89.87	14.90	4.13
temporal lobe, adult, pool1	10031-101E4	59.51	13.73	7.63
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	52.00	18.52	8.55
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	53.18	15.38	9.23
tenocyte, donor1	11763-123H8	44.34	8.73	3.49
tenocyte, donor2	11765-123I1	35.10	5.34	3.05
tenocyte, donor3	11768-123I4	53.75	8.15	2.59
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	72.23	9.52	5.27
teratocarcinoma cell line:NCR-G1	10798-110I6	35.92	5.09	4.62
teratocarcinoma cell line:PA-1	10807-111A6	40.14	5.27	6.04
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	43.80	9.27	3.55
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	67.31	6.05	8.70
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	27.48	4.69	2.29
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	106.50	13.68	5.54
testis, adult, pool1	10026-101D8	34.68	6.12	6.44
testis, adult, pool2	10096-102C6	47.36	13.08	6.32
thalamus - adult, donor10196	10168-103B6	59.62	15.46	6.62
thalamus, adult, donor10252	10154-103A1	107.37	16.25	10.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	67.74	20.02	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	38.87	8.23	3.79
thalamus, newborn, donor10223	10366-105F6	20.14	4.60	2.30
throat, adult	10209-103G2	53.93	6.74	5.74
throat, fetal, donor1	10061-101H7	48.45	9.14	8.23
thymic carcinoma cell line:Ty-82	10803-111A2	86.65	12.72	6.16
thymus, adult, pool1	10027-101D9	73.47	7.56	5.87
thymus, fetal, pool1	10043-101F7	97.67	9.77	8.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	51.85	5.72	3.19
thyroid carcinoma cell line:TCO-1	10783-110G9	26.26	3.07	3.35
thyroid, adult, pool1	10028-101E1	37.23	2.15	6.63
thyroid, fetal, donor1	10060-101H6	50.36	6.33	6.59
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	6.16	3.08
tongue, adult	10203-103F5	50.00	7.68	4.88
tongue, fetal, donor1	10059-101H5	49.26	5.52	10.25
tonsil, adult, pool1	10047-101G2	81.94	9.52	4.61
trachea, adult, pool1	10029-101E2	40.08	7.77	3.60
trachea, fetal, donor1	10058-101H4	46.16	5.00	6.16
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	32.95	6.73	4.96
transitional-cell carcinoma cell line:5637	10418-106C4	45.09	6.89	3.44
transitional-cell carcinoma cell line:JMSU1	10492-107B6	98.09	12.85	9.71
tridermal teratoma cell line:HGRT	10694-109G1	19.03	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	31.41	4.15	2.20
umbilical cord, fetal, donor1	10057-101H3	37.56	6.26	2.09
uterus, adult, pool1	10100-102D1	65.52	6.65	10.41
uterus, fetal, donor1	10055-101H1	43.00	8.70	8.19
vagina, adult	10204-103F6	21.32	1.29	5.17
vein, adult	10191-103E2	44.28	3.95	4.16
xeroderma pigentosum b cell line:XPL 17	10563-108A5	33.65	4.01	3.74